Dynamic Glucose Monitoring Patch Market to Grow at 18.3% CAGR Through 2031 Dynamic Glucose Monitoring Patch According to the recent report by QYResearch, the dynamic glucose monitoring patch market is witnessing a surge in demand and innovation, with the global market valued at USD 5,083 million in 2024 and projected to reach USD 16,480 million by 2031, reflecting a robust CAGR of 18.3% during the forecast period (2025–2031). This growth is largely driven by the increased prevalence of diabetes, the demand for continuous and non-invasive glucose monitoring, and the expansion of wearable healthcare technologies into the wellness and sports sectors. Additionally, new U.S. tariff policies introduced in 2025 have added uncertainty to the global economic landscape, pushing companies to localize supply chains and re-evaluate regional strategies. Leading Companies and Latest Developments Key global players in the market include: · Abbott Laboratories · Dexcom Inc. · Medtronic plc · Senseonics Holdings Inc. · Ascensia Diabetes Care · Roche Diabetes Care · Ypsomed AG · Medisana GmbH · Biocorp · Nemaura Medical · PKvitality · Philips Healthcare · GE Healthcare · Continua Health Alliance · GlucoRx Recent breakthroughs include Dexcom’s launch of the G7 15-Day CGM system with FDA approval for longer wear time, and Senseonics’ release of the Eversense 365—an implantable CGM offering continuous glucose tracking for up to a full year. Abbott has also diversified its CGM product line with 'Libre Rio' for diabetic patients and 'Lingo' for health-conscious consumers without diabetes. Dynamic Glucose Monitoring Patch Manufacturers - Product Model List 1. Abbott Laboratories · FreeStyle Libre 2 · FreeStyle Libre 3 · Libre Rio · Libre Sense · Lingo Biosensor 2. Dexcom Inc. · Dexcom G6 · Dexcom G7 · Dexcom G7 15-Day · Stelo (OTC CGM) 3. Medtronic plc · Guardian Sensor 3 · Guardian Sensor 4 · MiniMed 780G with SmartGuard · Enlite Sensor 4. Senseonics Holdings Inc. · Eversense E3 (180-day) · Eversense 365 (365-day implant) 5. Ascensia Diabetes Care · Contour Next One · Contour Plus One · Contour Care App Integration Series 6. Roche Diabetes Care · Accu-Chek Guide · Accu-Chek Instant · Accu-Chek Mobile · mySugr app-compatible devices 7. Ypsomed AG · YpsoPump · YpsoPod · mylife Loop · mylife Unio Neva 8. Medisana GmbH · Glucosense Bluetooth Patch · Medisana MediTouch Connect 9. Biocorp · Mallya Sensor for Pens · Biocorp Connected Patch 10. Nemaura Medical · SugarBEAT Patch · BEATdiabetes Wellness Patch 11. PKvitality · PKvitality K’Watch Glucose (micro-needle patch) 12. Philips Healthcare · Wearable biosensor patch (Vital Signs Monitoring) 13. GE Healthcare · Wireless Vital Patch · Biotelemetry Partnered CGM Systems 14. Continua Health Alliance · Interoperability Guidelines for CGMs · Certified connected CGM reference designs 15. GlucoRx · GlucoRx BioXensor · GlucoRx Nexus Voice · GlucoRx Bluetooth MultiCheck Market Segmentation By Type: · Continuous Glucose Monitoring Patches · Single-use Glucose Monitoring Patches · Multi-functional Health Monitoring Patches · Wearable Smart Device-based Monitoring Patches · Others By Application: · Home Monitoring for Diabetic Patients · Hospital and Clinical Monitoring · Sports and Fitness Health Management · Elderly Health Care · Others Emerging Trends The glucose monitoring market in 2025 is undergoing rapid transformation, fueled by technological innovation and evolving consumer expectations. Several critical trends are emerging, reshaping how continuous glucose monitoring (CGM) systems are developed, marketed, and utilized globally. 1. Over-the-Counter (OTC) Accessibility Devices such as Dexcom’s Stelo and Abbott’s Lingo have been released as over-the-counter (OTC) biosensors. In 2024, Dexcom launched Stelo, the first FDA-cleared OTC CGM aimed at non-insulin-using adults. It allows users to monitor glucose trends via smartphone apps without a prescription, drastically improving access. Abbott’s Lingo has also entered retail channels including Amazon, targeting wellness-focused users. These OTC advancements are expanding consumer reach and normalizing glucose monitoring in daily wellness routines. 2. Integration of Artificial Intelligence (AI) Leading CGM companies are integrating AI technologies to deliver enhanced, predictive health insights. Dexcom has introduced a generative AI platform that interprets glucose data patterns and offers personalized lifestyle recommendations. Meanwhile, clinical trials led by institutions like the University of Virginia are testing AI-powered insulin delivery algorithms, aiming to improve glycemic control and ease disease management. These developments signify a shift from reactive to proactive and personalized diabetes care. 3. Global Adoption and Market Growth The global uptake of CGM devices is accelerating. The Asia-Pacific market is expected to exceed USD 5.88 billion by 2030, driven by rising diabetes rates and better healthcare access. Latin America is also experiencing strong momentum, with a projected CAGR of 8.8% through 2030. Government initiatives, insurance coverage improvements, and increasing awareness are key contributors to adoption in emerging regions. 4. Technological Innovations Recent innovations include non-invasive sensors, improved battery life, and real-time data streaming. Biowearables now offer multiparameter monitoring, combining glucose tracking with fitness and sleep analytics. Devices such as Oura Ring are incorporating metabolic health indicators, expanding the scope of wearables. These innovations align with consumer demand for all-in-one health platforms. 5. Shift Toward Preventive Healthcare Glucose monitoring is increasingly being used by non-diabetic and pre-diabetic individuals as part of preventative care. Consumers are leveraging real-time glucose data to optimize diets, exercise routines, and sleep, aiming to prevent chronic diseases such as Type 2 diabetes. As a result, CGM patches are no longer seen solely as medical tools but as integral components of lifestyle and wellness management. In conclusion, 2025 marks a pivotal year for the dynamic glucose monitoring market. The convergence of OTC accessibility, AI integration, global expansion, and wellness-driven adoption is redefining the industry's scope and positioning CGMs as mainstream health tools rather than niche medical devices. Get free Sample report: Global Dynamic Glucose Monitoring Patch Market Research Report 2025 https://www.qyresearch.com/reports/4724637/dynamic-glucose-monitoring-patch Dynamic Glucose Monitoring Patch - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 https://www.qyresearch.com/reports/4724636/dynamic-glucose-monitoring-patch Global Dynamic Glucose Monitoring Patch Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031 https://www.qyresearch.com/reports/4724635/dynamic-glucose-monitoring-patch Global Dynamic Glucose Monitoring Patch Market Insights, Forecast to 2031 https://www.qyresearch.com/reports/4724634/dynamic-glucose-monitoring-patch About Us QYResearch founded in California, USA in 2007. It is a leading global market research and consulting company. With over 18 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 66,000 clients across five continents. Let’s work closely with you and build a bold and better future. Contact Us: If you have any queries regarding this report or if you would like further information, please contact us: QY Research Inc. Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States EN: https://www.qyresearch.com Email: global@qyresearch.com Tel: 001-626-842-1666(US)   JP: https://www.qyresearch.co.jp